Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism
- PMID: 30374468
- PMCID: PMC6199893
- DOI: 10.1210/js.2018-00187
Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism
Abstract
Context: The involvement of visceral fat in aldosterone secretion has not been reported in patients with primary aldosteronism (PA). Patients with PA are complicated by metabolic syndrome more frequently than those without PA. An excess of visceral fat has been hypothesized to cause an elevation of aldosterone secretion in patients with PA.
Objectives: To clarify the role of visceral fat in the pathophysiology of PA, we investigated the correlation between plasma aldosterone concentration (PAC) and visceral fat parameters in patients with PA.
Design: This retrospective observational study comprised 131 patients diagnosed with PA between April 2007 and April 2017 at Sapporo City General Hospital. We divided participants into two PA subtypes, aldosterone-producing adenoma (APA; n = 47) and idiopathic hyperaldosteronism (IHA, n = 84), utilizing adrenal venous sampling. We analyzed the correlations of PAC with visceral fat percentage (VF%), visceral fat area (VFA), and subcutaneous fat area, by evaluating computed tomography studies in each subtype group.
Results: Patients with IHA showed a positive correlation of PAC with VF% (r = 0.377, P < 0.001) and VFA (r = 0.443, P < 0.001). The correlation was not evident in patients with APA.
Conclusions: This study revealed a relationship between visceral adipose tissue and aldosterone production only in patients with IHA.
Keywords: hypertension; idiopathic hyperaldosteronism; obesity; primary aldosteronism; visceral adipose tissue.
Figures



Similar articles
-
Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment.J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70097. doi: 10.1111/jch.70097. J Clin Hypertens (Greenwich). 2025. PMID: 40685766 Free PMC article.
-
The risk factors for hepatic steatosis in patients with primary aldosteronism.Endocr J. 2020 Jun 29;67(6):623-629. doi: 10.1507/endocrj.EJ19-0600. Epub 2020 Mar 24. Endocr J. 2020. PMID: 32213734
-
Evaluation of Abdominal Computed Tomography Scans for Differentiating the Discrepancies in Abdominal Adipose Tissue Between Two Major Subtypes of Primary Aldosteronism.Front Endocrinol (Lausanne). 2021 Jul 16;12:647184. doi: 10.3389/fendo.2021.647184. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34335463 Free PMC article.
-
Detecting and treating primary aldosteronism: primary aldosteronism.Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):171-4. doi: 10.1055/s-2007-970409. Exp Clin Endocrinol Diabetes. 2007. PMID: 17427105 Review.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
Cited by
-
Impact of Primary Aldosteronism in Resistant Hypertension.Curr Hypertens Rep. 2022 Aug;24(8):285-294. doi: 10.1007/s11906-022-01190-9. Epub 2022 Apr 21. Curr Hypertens Rep. 2022. PMID: 35445928 Review.
-
Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism.Hypertens Res. 2023 May;46(5):1132-1144. doi: 10.1038/s41440-023-01170-9. Epub 2023 Feb 8. Hypertens Res. 2023. PMID: 36754972
-
Occurrence of Metabolic Disorders in Bilateral Primary Aldosteronism Compared to Unilateral Primary Aldosteronism.Diseases. 2025 Feb 10;13(2):52. doi: 10.3390/diseases13020052. Diseases. 2025. PMID: 39997059 Free PMC article.
-
Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.J Diabetes Investig. 2020 Nov;11(6):1511-1519. doi: 10.1111/jdi.13312. Epub 2020 Jun 26. J Diabetes Investig. 2020. PMID: 32470155 Free PMC article.
-
Clinical and biochemical outcomes after adrenalectomy for primary aldosteronism in tertiary and quaternary referral centers: data from SOPRANO study.Hypertens Res. 2024 Mar;47(3):721-734. doi: 10.1038/s41440-023-01554-x. Epub 2024 Jan 5. Hypertens Res. 2024. PMID: 38182902
References
-
- Chiang BN, Perlman LV, Epstein FH, Epstein FH. Overweight and hypertension. A review. Circulation. 1969;39(3):403–421. - PubMed
-
- Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4(1):20–34. - PubMed
-
- Nicklas BJ, Penninx BW, Ryan AS, Berman DM, Lynch NA, Dennis KE. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care. 2003;26(5):1413–1420. - PubMed
-
- Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007;66(5):607–618. - PubMed
-
- Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies--a review of the current literature. Horm Metab Res. 2012;44(3):157–162. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous